Overview
Isomorphic Labs is a new Alphabet company and commercial venture which aims to reimagine the entire drug discovery process from first principles with an AI-first approach. Founded on the principles of using artificial intelligence to transform drug discovery, it builds on the Nobel-winning AlphaFold system.
Funding
Amounts as reported; USD estimates shown only when they matchListed 2 funding records. Latest funding: $2.1B (Series B), May 12, 2026.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| May 12, 2026 | $2.1B · Series B | Alphabet, CapitalG, MGX, Thrive Capital, 淡马锡 | 1 source Source ↗ |
Evidence Isomorphic Labs raises USD 2.1 billion Series BOn 2026/5/12, X reported that UK AI drug discovery company Isomorphic Labs, led by Demis Hassabis, had raised USD 2.1 billion in Series B funding to shorten drug development cycles. Translated source brief, not a quotation. Check the original before citing. Sources · 1
| |||
| Mar 31, 2025 | $600M · Strategic | Alphabet, Google Ventures, Thrive Capital | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
Select ▸ on a row to see its source brief and links.
Valuation
Amounts as reported; USD estimates shown only when they matchListed 2 valuation records.
No chartable valuation estimates yet.
2 listed records lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| May 12, 2026 | — · Series B | Alphabet, CapitalG, MGX, Thrive Capital, 淡马锡 | 1 source Source ↗ |
Evidence Isomorphic Labs raises USD 2.1 billion Series BOn 2026/5/12, X reported that UK AI drug discovery company Isomorphic Labs, led by Demis Hassabis, had raised USD 2.1 billion in Series B funding to shorten drug development cycles. Translated source brief, not a quotation. Check the original before citing. Sources · 1
| |||
| Mar 31, 2025 | — · Strategic | Alphabet, Google Ventures, Thrive Capital | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
Select ▸ on a row to see its source brief and links.
Revenue
Amounts as reported; USD estimates shown only when they matchNo revenue records are listed yet.
No revenue rows to list.
Team, products & investors
Explore
More Applications companies
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
Alphabet旗下AI药物研发公司，用AI加速药物发现 Isomorphic Labs is a new Alphabet company and commercial venture which aims to reimagine the entire drug discovery process from first principles with an AI-first approach. Founded on the principles of using artificial intelligence to transform drug discovery, it builds on the Nobel-winning AlphaFold system.